Soluble receptor for advanced glycation end products (sRAGE) is present at high concentrations in the lungs of children and varies with age and the pattern of lung inflammation

Respirology

Volumn 17, Issue 5, 2012, Pages 841-846

  Yerkovich, Stephanie T ^a,b   Chang, Anne B ^c,d   Carroll, Melanie L ^a   Petsky, Helen L ^c   Scrivener, Greta ^c   Upham, John W ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

bronchoalveolar lavage fluid; inflammation; lung; soluble receptor for advanced glycation end products

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

AGE; ARTICLE; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; LUNG; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TISSUE LEVEL;

ADOLESCENT; ADULT; AGING; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CHILD; FEMALE; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULIN A; LUNG; MALE; MULTIVARIATE ANALYSIS; PNEUMONIA; RECEPTORS, IMMUNOLOGIC; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84863005549     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2012.02174.x     Document Type: Article

References (26)

1. Yerkovich ST, Wikstrom ME, Suriyaarachchi D, et al,. Postnatal development of monocyte cytokine responses to bacterial lipopolysaccharide. Pediatr. Res. 2007; 62: 547-52. (Pubitemid 351338988)
2. Bierhaus A, Humpert PM, Morcos M, et al,. Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 2005; 83: 876-86. (Pubitemid 41598688)
3. Schmidt AM, Yan SD, Yan SF, et al,. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Invest. 2001; 108: 949-55. (Pubitemid 32946067)
4. Hofmann MA, Drury S, Hudson BI, et al,. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun. 2002; 3: 123-35. (Pubitemid 38961122)
5. Park L, Raman KG, Lee KJ, et al,. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation end products. Nat. Med. 1998; 4: 1025-31. (Pubitemid 28417334)
6. Cheng C, Tsuneyama K, Kominami R, et al,. Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs. Mod. Pathol. 2005; 18: 1385-96. (Pubitemid 41348659)
7. Englert JM, Hanford LE, Kaminski N, et al,. A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Am. J. Pathol. 2008; 172: 583-91. (Pubitemid 351354532)
8. Shirasawa M, Fujiwara N, Hirabayashi S, et al,. Receptor for advanced glycation end-products is a marker of type I lung alveolar cells. Genes Cells 2004; 9: 165-74. (Pubitemid 38312960)
9. Calfee CS, Ware LB, Eisner MD, et al,. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 2008; 63: 1083-9.
10. Uchida T, Shirasawa M, Ware LB, et al,. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am. J. Respir. Crit. Care Med. 2006; 173: 1008-15.
11. Jabaudon M, Futier E, Roszyk L, et al,. Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients. Crit. Care Med. 2011; 39: 480-8.
12. Mauri T, Masson S, Pradella A, et al,. Elevated plasma and alveolar levels of soluble receptor for advanced glycation end products are associated with severity of lung dysfunction in ARDS patients. Tohoku J. Exp. Med. 2010; 222: 105-12.
13. van Zoelen MA, Schouten M, de Vos AF, et al,. The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia. J. Immunol. 2009; 182: 4349-56.
14. Queisser MA, Kouri FM, Konigshoff M, et al,. Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types. Am. J. Respir. Cell Mol. Biol. 2008; 39: 337-45.
15. Smith DJ, Yerkovich ST, Towers MA, et al,. Reduced soluble receptor for advanced glycation end-products in COPD. Eur. Respir. J. 2011; 37: 516-22.
16. Lizotte PP, Hanford LE, Enghild JJ, et al,. Developmental expression of the receptor for advanced glycation end-products (RAGE) and its response to hyperoxia in the neonatal rat lung. BMC Dev. Biol. 2007; 7: 15.
17. Chang AB, Moloney GE, Harms PJ, et al,. Endoscopic intratracheal carbon dioxide measurements during pediatric flexible bronchoscopy. Paediatr. Anaesth. 2004; 14: 650-5. (Pubitemid 39070559)
18. de Blic J, Midulla F, Barbato A, et al,. Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society. Eur. Respir. J. 2000; 15: 217-31.
19. Christie JD, Shah CV, Kawut SM, et al,. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. Am. J. Respir. Crit. Care Med. 2009; 180: 1010-5.
20. Determann RM, Wolthuis EK, Choi G, et al,. Lung epithelial injury markers are not influenced by use of lower tidal volumes during elective surgery in patients without preexisting lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008; 294: L344-50. (Pubitemid 351253371)
21. Sinden NJ, Stockley RA,. Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence. Thorax 2010; 65: 930-6.
22. Carroll L, Frazer IH, Turner M, et al,. Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis. Arthritis Res. Ther. 2007; 9: R39.
23. Chen YS, Yan W, Geczy CL, et al,. Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis. Arthritis Res. Ther. 2009; 11: R39.
24. Hancock DB, Eijgelsheim M, Wilk JB, et al,. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat. Genet. 2010; 42: 45-52.
25. Repapi E, Sayers I, Wain LV, et al,. Genome-wide association study identifies five loci associated with lung function. Nat. Genet. 2010; 42: 36-44.
26. Forbes JM, Soderlund J, Yap FY, et al,. Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes. Diabetologia 2011; 54: 1032-42.